DE:AP82 / Aptevo Therapeutics Inc. - Kepemilikan Institusional - Pembeli

Aptevo Therapeutics Inc.
DE ˙ DB
Institusi dan Kepemilikan Dana - Pembeli

Pemegang saham utama yang telah membuka posisi baru di Aptevo Therapeutics Inc. termasuk Gsa Capital Partners Llp, Vanguard Group Inc, Geode Capital Management, Llc, Vanguard Capital Management Llc, dan Vanguard Fiduciary Trust Co .

Halaman ini menunjukkan perubahan struktur kepemilikan berdasarkan daftar institusi, dana, dan pemegang saham utama yang telah meningkatkan kepemilikannya atau membuka posisi baru pada periode pelaporan terakhir. Baris hijau menunjukkan posisi baru. Klik tautannya ikon untuk melihat riwayat transaksi lengkap.

Upgrade untuk membuka data premium.

Tanggal Berkas Sumber Investor Jenis Harga Rata-rata
(Perkiraan)
Saham Δ Saham
(%)
Dilaporkan
Nilai
($1000)
Δ Nilai
(%)
Alokasi Portofolio
(%)
2026-05-15 13F Geode Capital Management, Llc 13.337 57
2026-01-29 13F Vanguard Group Inc 16.856 159
2026-05-08 13F Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 4.142 18
2026-04-28 13F SBI Securities Co., Ltd. 109 251,61 0
2026-05-08 13F Gsa Capital Partners Llp 19.638 0
2026-05-05 13F UBS Group AG 3.445 1.926,47 15 1.300,00
2026-05-15 13F/A Vanguard Capital Management Llc 12.713 54
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:APVO US$4,72
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista